| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |